| 일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
- 비만치료제
- danuglipron
- GLP-1 치료제
- Viking Therapeutics
- 제약바이오
- lilly
- gsbr-1290
- CAR-T in autoimmune
- 노보노디스크
- VKTX
- Novo Nordisk
- il-17 inhibitor
- Semaglutide
- Mash
- CAR-T
- VK2735
- tirzepatide
- tern-601
- 바이오스터디
- glp-1 비만
- 자가면역질환 치료제
- Efruxifermin
- orforglipron
- 경구용 glp-1
- Pegozafermin
- GPCR
- ct-996
- GLP-1치료제
- Nash
- GLP-1
- Today
- Total
목록주절주절 (17)
제약바이오 츄롸이츄롸이!~
2024-05-09 Fate Therapeutics 실적발표 + 2024 ASGCT 학회 자료 발표https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-reports-first-quarter-2024-financial-results Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates | Fate Therapeutics, Inc.The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockho..
Cullinan Therapeutics Corporate Update (2024-04-16)
Cullinan Oncology (NASDAQ: CGEM)이 사명 변경과 함께 전략 수정 발표 https://investors.cullinantherapeutics.com/news-releases/news-release-details/cullinan-therapeutics-announces-strategic-expansion-autoimmune Cullinan Therapeutics로 사명 정정. CLN-978 (CD19xCD3 이중항체) B-NHL에서 자가면역질환으로 개발계획 변경 또하나의 CD19 관련 물질 항암제보다 자가면역질환으로 focus 전환 CLN-978은 albumin binding domain이 추가된 scFV 구성의 이중항체 CD19과 CD3 binding affinity는 잘 나와있지..
Novo Nordisk - Capital Market Day 2024 (2024-03-07) #1
Novo Nordisk - Capital Market Day 2024 (2024-03-07) 2024.03.08 - [주절주절] - Novo Nordisk - Capital Market Day 2024 (2024-03-07) Novo Nordisk - Capital Market Day 2024 (2024-03-07) https://novo.evenzu.com/stream/cmd2024 https://novo.evenzu.com/stream/cmd2024 novo.evenzu.com Novo Nordisk - Capital Market Day 2024 (2024-03-07) 첨부파일이랑 세션을 다 듣지는 않으니 관심 있는것만 저장 Research & Early Development P churaichura..
Novo Nordisk - Capital Market Day 2024 (2024-03-07)
https://novo.evenzu.com/stream/cmd2024 https://novo.evenzu.com/stream/cmd2024 novo.evenzu.com Novo Nordisk - Capital Market Day 2024 (2024-03-07) 첨부파일이랑 세션을 다 듣지는 않으니 관심 있는것만 저장 Research & Early Development Product Supply Diabetes Care Obesity Care Rare Disease Cardiovascular & Emerging Therapy Areas Break-Out Session: Data Science and AI
AstraZeneca 2023 ESMO - Meet AZN Management (2023-10-23)
https://www.astrazeneca.com/content/astraz/investor-relations/meet-azn-management-esmo-congress-2023.html Meet AZN management: European Society for Medical Oncology (ESMO) Congress 2023 www.astrazeneca.com 2023 ESMO에서 AstraZeneca가 Investor Event한 자료 (2023-10-23) ADC @ AstraZeneca: Bispecfiics @ AstraZeneca: 결과들이 재밌게 나오는 이중항체들 Volrustomig (PD-1 x CTLA-4) Rilvegostomig (PD-1 x TIGIT) Sabestomig (P..
Pfizer Oncology Innovation Day (2024-02-29) #2
Pifzer Oncology Innovation Day https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Oncology-Hosts-Innovation-Day-Highlighting-Fully-Integrated-Organization-Robust-Portfolio-and-Strategic-Priorities-to-Drive-Long-Term-Sustainable-Growth/default.aspx 나중에 생각나면 다시 보기 위해 정리. 세션으로는 크게: - GU Cancer - Thoracic Cancer - Breast Cancer - Haemato-Oncology - Next-Generation R&D Breast Cancer..
Pfizer Oncology Innovation Day (2024-02-29) #1
Pifzer Oncology Innovation Day https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Oncology-Hosts-Innovation-Day-Highlighting-Fully-Integrated-Organization-Robust-Portfolio-and-Strategic-Priorities-to-Drive-Long-Term-Sustainable-Growth/default.aspx 나중에 생각나면 다시 보기 위해 정리. 세션으로는 크게: - GU Cancer - Thoracic Cancer - Breast Cancer - Haemato-Oncology - Next-Generation R&D PADCEV (Enfro..